Catalent
CTLT
#1737
Rank
โ‚น1.035 T
Marketcap
โ‚น5,703
Share price
0.00%
Change (1 day)
20.71%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Last known market cap: โ‚น1.035 Trillion

On February 19, 2025 Catalent had a market cap of โ‚น1.035 Trillion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.035 T4.72%
2024โ‚น988.46 B46.3%
2023โ‚น675.66 B0.8%
2022โ‚น670.29 B-60.7%
2021โ‚น1.705 T36.08%
2020โ‚น1.253 T113.27%
2019โ‚น587.76 B85.13%
2018โ‚น317.48 B-8.9%
2017โ‚น348.48 B52.48%
2016โ‚น228.54 B10.34%
2015โ‚น207.12 B-5.32%
2014โ‚น218.77 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Supernus Pharmaceuticals
SUPN
โ‚น235.30 B-77.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น67.70 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น926.37 B-10.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚น71.39 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA